Agreement between spirometry and tracheal auscultation in assessing bronchial responsiveness in asthmatic children  by Sprikkelman, A.B. et al.
RESPIRATORY MEDICINE (1999) 93, 102-107 
Agreement between spirometry and tracheal 
auscultation in assessing bronchial responsiveness 
in asthmatic children 
A. B. SPRIKKELMAN~, J. P. SCHOUTEN~, M. S. LOURENS”, H. S. A. HEYMANS* AND 
W. M. C. VAN AALDEREN* 
“Beatrix Children’s Hospital,’ University Hospital Groningen 
‘Department of Epidemiology and Statistics, University of Guoningen, and 
*Emma Children’s Hospital, Academic Medical CentevlUniveusity of Amsterdam, The Netherlands 
We have recently found that changes in lung sounds correspond well with a 20% fall in the forced expiratory volume 
in 1 s (FEV,) after methacholine challenge in asthmatic children. Up to now, little was known about the agreement 
between a 20% fall in FEV, and a change in lung sounds after repeated bronchial challenge. 
In this study we investigated the agreement between the total cumulative histamine dose causing a fall in FEV, of 
20% or more (PD,,) and the detection of a change in lung sounds (PD lung sounds) after two bronchial challenges on 
different occasions in asthmatic children. 
Fifteen asthmatic children (nine boys), mean age 10.8 years (range g-15), were studied. All performed two 
histamine challenge tests on 2 days, with a 24 h to 1 week interval. Lung sounds were recorded over the trachea for 
1 min and stored on tape. Lung sounds were analysed directly and also scored from the tape-recording by a blinded 
second investigator. Wheeze, cough, and an increase in respiratory rate were assessed. The relationship between 
Pbo and PQ,,, sounds was calculated by Bland and Altman’s measurement of agreement. 
Eleven children had a positive challenge test (PD 20 < 16.0 mg ml- ‘) on both test days; four had a positive 
challenge on one test day. In 24 out of 26 positive challenges, wheeze, cough, prolonged expiration and/or increased 
respiratory rate were detected one dose-step before, or at the dose-step of histamine that induced a fall in FEV, of 
20% or more. In two challenges, PD,, was not detected by a change in lung sounds. In four out of four negative 
challenges (PD,, > 16.0 mg ml - ‘) no change in lung sounds could be detected. Good agreement between the 
logarithm of PD,, and the logarithm of PDI,,, sounds was found on both test days. The mean difference was 0.04 and 
the limits of agreement (d& 2 SD of the differences) were 0.04 f 0.41. 
A good agreement was found between the total cumulative histamine dose causing a fall in FEV, of 20% or more 
and the detection of a change in lung sounds after two bronchial challenges on different occasions in asthmatic 
children. 
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Introduction 
Histamine or methacholine bronchial inhalation challenge 
is a well-known measurement for assessing bronchial 
responsiveness in adults and children, and has been proven 
to be useful in the diagnosis and evaluation of asthma. 
However, spirometric tests which require active cooper- 
ation in forced expiratory manoeuvres cannot be used in 
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infants and young children because of their inability to 
perform these tests reliably (1). An alternative technique 
based on detecting audible wheeze over the trachea and 
requiring passive cooperation only has been described for 
bronchial inhalation challenge tests in children (2). In older 
children, a close correlation has been observed between the 
20% fall in forced expiratory volume in 1 s (FEV,) after 
bronchial provocation challenge and the occurrence of 
wheeze (2,3). Recently, we found that not only the appear- 
ance of wheeze, but also other changes in lung sounds 
correspond well with a 20% fall in FEV, after bronchial 
challenge with methacholine (4). Wheeze by itself was 
shown not to be a sensitive indicator for assessing bronchial 
responsiveness, but cough, increase in respiratory rate and 
prolonged expiration were more frequently found at the 
20% fall in FEV,. 
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Changes in lung sounds detected by tracheal auscultation 
would offer an attractive method for assessment of bron- 
chial responsiveness in children who are not able to perform 
spirometry if changes in lung sounds correspond with a 
20% fall in FEV, and do so repeatably. However, little is 
known about the agreement between a 20% fall in FEV, 
and the detection of a change in lung sounds after bronchial 
challenge on different occasions. We therefore investigated 
the relationship between the total cumulative histamine 
dose causing a fall in FEV, of 20% or more (PD& and the 
detection of a change in lung sounds after two bronchial 
challenges on different occasions in asthmatic children. 
Methods 
SUBJECTS 
Fifteen children (nine boys) with mild to moderate asthma 
(4), without concomitant diseases and aged 9-15 years 
(mean 10.8 years), were recruited from the outpatient clinic 
of the Beatrix Children’s Hospital in Groningen, The 
Netherlands. All children had a PD,,-histamine 
ISmgml -i in the year before this study was performed. 
All children used daily inhaled corticosteroids, with a 
dosage ranging from 200 to 400,~~g twice daily and used 
bronchodilator therapy on demand. None of the children 
used oral corticosteroids. The mean baseline Tiffeneau 
index (FEV, vital capacity ~ ‘) before the histamine inhala- 
tion challenge test was 87% of predicted (range 66695%). 
All children performed two histamine challenge tests on 2 
days, at the same time of day, and separated by 24 h to 1 
week. The first challenge with histamine was requested as 
part of the children’s routine evaluation. They were asked 
to perform a second challenge test in order to assess the 
repeatability of the tracheal auscultation method. No child 
had a history of a respiratory tract infection for at least 1 
month before the challenge tests or between the two test 
days. Bronchodilator therapy was withheld for at least 8 h 
(short-acting) or 24 h (long-acting) before testing to allow 
histamine-induced bronchoconstriction to occur. Inhaled 
corticosteroids were continued. All children had normal 
chest auscultation before the histamine inhalation challenge 
test. Informed consent was obtained from the child and 
parents. The study was approved by the Medical Ethics 
Committee of the University Hospital Groningen. 
INHALATION CHALLENGE TEST 
The children performed spirometric tests using the 
Spirometry/Flow-Volume Program (version 4.34, Jaeger, 
Wiirzburg, Germany). The best result of three FEV, 
attempts was used for analysis. Histamine inhalation was 
preceded by baseline lung function measurements, followed 
immediately by the inhalation of phosphate-buffered saline 
as a control. After inhalation of the phosphate-buffered 
saline, doubling concentrations of histamine (beginning 
with 0.03 mg ml - i to a maximum of 16.0 mg ml- ‘) 
were administered during four inhalations through the 
Asthma Provocation System nebulizer (version SA, Jaeger, 
Wtirzburg, Germany), with a calibrated output of 5,ul per 
puff. The aerosol was delivered into the mouth piece while 
the children were wearing a nose clip. During each inhala- 
tion of the aerosol, a deep breath was taken and held for 
10 s. Three minutes after the fourth inhalation of the 
aerosol, FEV, measurements were performed. Successive 
concentrations of histamine solutions were given at 5-min 
intervals. The provocation tests were discontinued if the 
FEV, decreased by 20% or more from the baseline or when 
the maximum dose of histamine was reached. Bronchial 
responsiveness was defined as the total cumulative dose of 
histamine inducing a 20% or more fall in FEV, (PD& 
TRACHEAL AUSCULTATION 
The trachea auscultation method was performed according 
to the protocol as described previously (5). Lung sounds 
were recorded over the trachea by a microphone (Wip en 
Broos, Winsum, The Netherlands) placed in the supraster- 
nal notch and attached to the skin with two-sided adhesive 
tape rings. Lung sounds were recorded for 1 min starting 
2 min after administration of each dose of histamine (before 
FEV, measurements) during quiet respiration. Lung sounds 
were stored on tape (DT-120 Rn, Sony), using a digital 
audio tape recorder (DTC-59 ES, Sony) and were analysed 
by headphone (Beyer Dynamic DT 801, Badhoevedorp, 
The Netherlands). The lung sounds were scored directly 
(A.B.S.) as wheeze, cough, prolonged expiration, and 
increase in respiratory rate. Cough was scored if it was 
persistent, i.e. continuously coughing after inhalation of 
histamine. Prolonged expiration was scored when the dur- 
ation of expiration exceeded the duration of inspiration. 
Increase in respiratory rate was defined as an increase of 
50% or more from the baseline respiratory rate. A second 
analysis of the lung sounds was scored blindly from the 
audio tape-recordings by a senior pediatric pulmonologist, 
who was unaware of the patient characteristics, baseline 
lung function, and the histamine concentrations applied 
(W.M.C.A.). For this second analysis lung sounds of all 
subjects were recorded on tape, without indicating patient 
data or stage of the challenge at which the lung sounds 
were recorded. The total cumulative histamine dose at 
which a change in lung sounds was heard was defined as 
PD lung sounds. 
STATISTICAL ANALYSIS 
The agreement between the PD,,-histamine and the 
PD ,ung sounds was calculated by Bland and Altman’s (6) 
measurement of agreement, and the intraclass correlation 
coefficient (7). The logarithms of PD,,-histamine and 
P&m, sounds were used for these calculations. Those sub- 
jects who inhaled 16 mg ml - i histamine without reaching a 
fall in FEV, of 20% were considered to have a negative 
challenge test. For statistical analysis, they were considered 
to have a PD,, or PDi,,, sounds of 32 mg ml - ‘. To account 
for the repeated studies and for the possible effects of the 
day at which bronchial challenges were performed, a 
maximum-likelihood method was used, based on the model 
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TABLE 1. Characteristics of patients and lung function testing 
Histamine (mg ml - ‘) 
Maximum fall 
in FEV, 
Patient Age FEV,NC (fall in FEV, at 
no. (years) Test (%I PDx P%n, sounds PD,un, sounds)# (%I Lung sounds 
1 
2 
3 
8 
9 
10 
11 
12 
13 
14 
15 
13 
9 
10 
10 
14 
10 
10 
9 
11 
7 
15 
13 
8 
11 
12 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
85 8.0 >16.0 20.0 
80 16.0 16.0 41.7 
88 16.0 8.0 31.6 (17.5) 
89 16.0 8.0 20.0 (11.6) 
78 4.0 4.0 23.8 
78 8.0 4.0 39.6 (7.5) 
78 16.0 16.0 21.2 
78 16.0 >16.0 20.0 
78 16.0 16.0 40.9 
76 >16.0 >16.0 0.0 
95 8.0 8.0 30.0 
95 >16.0 >16.0 18.1 
90 16.0 16.0 43.3 
90 >16.0 >16.0 17.4 
95 >16.0 >16.0 9.8 
93 16.0 16.0 25.0 
77 8.0 8.0 21.7 
75 16.0 16.0 30.8 
69 8.0 8.0 20.0 
70 8.0 8.0 23.1 
69 X.0 X.0 27.9 
66 16.0 16.0 30.6 
71 4.0 4.0 29.1 
63 8.0 8.0 23.2 
92 16.0 16.0 25.6 
89 16.0 8.0 26.0 (18.0) 
67 4.0 1.0 20.6 (13.5) 
69 4.0 2.0 25.1 (18.3) 
69 0.5 0.5 22.5 
66 4.0 4.0 27.7 
None 
Wheeze, prolonged expiration 
Wheeze, cough, prolonged 
expiration 
Wheeze, cough 
Wheeze, prolonged expiration 
Wheeze, cough, prolonged 
expiration 
Wheeze, cough 
None 
Cough 
None 
Cough 
None 
Wheeze, prolonged expiration, 
increased respiratory rate 
None 
None 
Wheeze 
Wheeze 
Prolonged expiration 
Wheeze, cough, prolonged 
expiration 
Wheeze, cough, prolonged 
expiration 
Wheeze, prolonged expiration 
Wheeze 
Wheeze, cough, prolonged 
expiration 
Wheeze, cough, prolonged 
expiration 
Wheeze 
Wheeze, prolonged expiration 
Wheeze, prolonged expiration 
Wheeze, prolonged expiration 
Wheeze, prolonged expiration 
Wheeze, prolonged expiration 
FEV,=forced expiratory volume in 1 s; VC=vital capacity; PD,,=dose of histamine causing a 20% fall in FEV,; 
PD iung sounds=dose of histamine at which a change in lung sounds was heard; #=if PDwheeze did not equal PD,,, the fall in 
FEV, at which a change in lung sounds was detected is shown. 
described by Laird and Ware (8) and Davidian and 
Giltinan (9). The linear mixed-effects model implemented in 
S-plus (10) was used with a random effect of the intercept, 
with an unrestricted variance matrix, and assuming 
independent within-person errors with constant variance. 
Results 
The subject characteristics and results of the lung function 
tests are shown in Table 1. 
Eleven out of 15 children (patient numbers l-4 and 9-15) 
had a positive challenge test (PD,, < 16.0 mg ml ~ ‘) on 
both test days. Four children (patient numbers 5-8) had a 
positive challenge test on one test day. In 24 out of 26 
positive challenges, wheeze, cough, prolonged expiration 
and/or increased respiratory rate were detected. In 18 
positive challenges, changes in lung sounds were detected 
after a fall in FEV, of 20% or more. In six positive 
challenges, changes in lung sounds were detected before a 
fall in FEV, of 20% was observed. In these challenges, the 
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FIG. 1. Agreement between the logarithms of PD,,- 
histamine and PD,,,, sounds on both test days. PD,,=total 
cumulative histamine dose causing a fall in FEV, of 20% 
or more; PD,,,, sounds =total cumulative histamine dose at 
which a change in lung sounds was heard; log=logarithm; 
dh 2 s~=O.04 * 0.41; d=mean difference; 2 sD=standard 
deviation with limits of agreement. 
fall in FEV, at which a change in lung sounds was detected 
ranged from 7.5 to 18.3% (patient numbers 3, 13, 14). In 
two positive challenge tests (patient numbers 1 and 4) no 
change in lung sounds could be detected despite a fall of 
20% in FEV,. In all four negative challenges (PD,, 
> 16.0 mg ml - ‘) no change in lung sounds could be 
detected. 
None of the children showed signs of dyspnoea, cyanosis, 
or intercostal retractions during the challenge tests. Com- 
plete agreement was found between the lung sounds scored 
directly and the lung sounds scored blindly during the 
subsequent audio tape recording analysis. 
A good agreement between the logarithm of PD,,- 
histamine and the logarithm of PD,,,, sounds was found on 
both test days (Fig. 1). The mean difference (d) was 0.04 
and the limits of agreement (d * 2 SD of the differences) 
were 0.04 f 0.41. The mean difference and the limits of 
agreement are depicted in Fig. 1. A good agreement was 
also found between the logarithms of PD,,-histamine and 
Phq sounds on both the first and the second test days. The 
mean difference and the limits of agreement were 
0.02 * 0.48 and 0.06 i 0.34 for the first and second test 
days, respectively. Moderate agreement was found between 
the logarithm of the PD,,-histamine measured on the first 
and second test days, and between the logarithm of the 
PD iung sounds measured on both days. The mean differences 
and limits of agreement were - 0.22 =t 0.58 and - 0.18 f 
0.34, repectively. The intraclass correlation coefficients of 
the logarithms of the PD,,-histamine and PD,,,, sounds on 
the first and second days were 0.56 and 0.66, respectively. A 
significant difference was found between the PD,,- 
histamine values measured on the first and second test days 
(P=O.O07; likelihood ratio=7.27; difference between test 
days 1 and 2=0.22). A significant difference was also found 
between the PQ,,, sounds values measured on both occa- 
sions (P=O.O45; likelihood ratio=4.01; difference between 
test days 1 and 2=0.18). No statistically significant effect 
of the day was found (P=O,O8; likelihood ratio=3.06; 
difference between day 1 and 2=0.09). 
Discussion 
This study shows good agreement beiween the total cumu- 
lative histamine dose causing a fall in FEV, of 20% or more 
and the detection of a change in lung sounds after two 
bronchial challenges on different occasions in asthmatic 
children. Despite statistically significant differences between 
the PD,,-histamine measured on test days 1 and 2, and 
between the PQul,, sounds measured on both occasions, a 
good agreement was found between PD,, and PD,,,, sounds. 
No statistical effect of the day on which the 
bronchial challenge was performed could be found. 
To our knowledge there are no published data concern- 
ing the agreement between the detection of PD,,-histamine 
and a change in lung sounds on two occasions, using the 
subjective tracheal auscultation method described in this 
and our earlier study (5). However, Sanchez et al., using a 
computerized analysis of respiratory sounds, found a good 
reproducibility of acoustic meaurements during metha- 
choline challenge in children with suspected asthma (11) 
and with cystic fibrosis (12). In contrast, Spence et al., in a 
study of six adult asthmatic patients during methacholine 
challenge, found that the level of FEV, at which audible 
wheeze appeared was not reproducible, differing widely 
both between patients and also within patients on different 
test days (13). Moreover, they showed a lack of reproduc- 
ibility of the changes in mean and median breath sound 
frequencies (13). Spence et al. also performed a computer- 
ized analysis of lung sounds. In both these studies (Sanchez 
et al. and Spence et al.) the sound analysis was limited to 
the detection of wheeze. Moreover, the subject of investi- 
gation in these studies was the repeatability of acoustic 
measurements in relation to airflow obstruction and not the 
repeatability of the agreement between the concentration of 
methacholine inducing a fall in FEV, of 20% or more and a 
change in lung sounds. 
Our observation that the appearance of wheeze is not the 
only indicator of bronchial reponsiveness, but that the 
appearance of cough, increase in respiratory rate, and a 
prolonged expiration are also significant, is in accordance 
with our previous study (5). This is in contrast with the 
observations of Avital et al. and Noviski et al., who used 
the occurrence of wheeze only as an indicator for bronchial 
responsiveness (2,3). Although Noviski et al. observed the 
occurrence of transient coughing, increase in respiratory 
rate, mild wheezing over the lung fields, and localized 
crepitations in some children, these changes in lung sounds 
did not correlate with either the concentration of metha- 
choline causing wheeze or the concentration causing 
the FEV, to fall by 20% (3). Adinoff et al.; however, 
described a methacholine inhalation challenge test in which 
the end-point was expressed as the concentration of 
methacholine which induced clinical signs of cough, 
wheeze, respiratory distress, and/or intercostal retractions 
(14). Sanchez et al. also reported the appearance of 
cough at the concentration of methacholine which induced 
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a fall in FEV, of 20% or more during bronchial challenge 
tests (11). 
In order to apply our tracheal auscultation method to 
younger children, further studies should be performed in 
this age group because it is possible that younger children 
may respond differently from older children to a histamine 
bronchial challenge test. In animal studies, increased bron- 
chial reponsiveness has been demonstrated in immature 
subjects compared with mature subjects (15). In humans, 
increased bronchial responsiveness has been demonstrated 
in healthy children aged 5-11 years in comparison with 
adolescents, and adults (16). Also, airways reactivity has 
been reported in healthy infants, as demonstrated by 
bronchoconstriction with methacholine, and the subsequent 
bronchodilatation with a bronchodilator agent (17). The 
results of these studies show that infants and younger 
children can exhibit bronchial reponses which may be 
falsely interpreted as bronchial hyperresponsiveness. How- 
ever, Avital et al. (2,18) have demonstrated a good corre- 
lation between the degree of bronchial reponsiveness and 
the severity of asthma symptoms in older as well as in 
younger children. In one study they investigated the use of 
the tracheal auscultation method during methacholine chal- 
lenge in two groups of children (2). The first group included 
15 children with asthma, aged 6-15 years (mean age 10 
years), who performed spirometry and tracheal ausculta- 
tion. The second group included 75 young children aged 
l-8 years (mean age 4.6 years), who were unable to perform 
spirometry reliably and only performed tracheal ausculta- 
tion. The children were subdivided into subgroups, within 
which clinical asthma was classified according to the min- 
inmal therapeutic requirement for optimal control of symp- 
toms. In this latter study it was demonstrated that the 
results of the tracheal auscultation showed a close relation- 
ship between the degree of clinical bronchial responsiveness 
and the severity of asthma in both groups. Interestingly, the 
mean methacholine concentration causing audible wheeze 
(the end point of the test) in both groups of children was 
similar to that found in adults for broadly similar therapeu- 
tic groups (19,20). In another study, Avital et al. (18) 
compared bronchial reponsiveness to methacholine in chil- 
dren of different age groups (aged 1-17 years), and with 
asthma of different severity, and found that bronchial 
responsiveness was independent of age, but distinguished 
between severity groups. Adinoff et al. (14) also found good 
agreement between positive methacholine challenge tests 
(defined as the occurence of respiratory distress or wheeze), 
and the severity of symptoms in young children aged l-5.8 
years. Very recently, Guirau et al. (21) have investigated the 
provocative concentration of methacholine causing wheeze 
(PC wheeZe) in children under 2 years of age with a history of 
wheeze, and in healthy children of the same age group, and 
correlated these data with the clinical progression of these 
children at admission and at follow-up. They found a 
significant inverse relationship between PCwheeze values and 
the severity of clinical symptoms. Thus, it is possible that 
young children may respond differently from older children 
to bronchial challenges; however, these latter studies show 
a close relationship between the clinical severity of 
asthma symptoms and PCwheeZe,iung sounds, suggesting that 
P~wheeze/lung sounds indicates a degree of bronchial 
responsiveness which is independent of age. 
In conclusion, this is the first study to investigate and 
demonstrate a good agreement between spirometry and 
subjective tracheal auscultation in assessing bronchial 
reponsiveness on different occasions in asthmatic children. 
The present study confirms our earlier observation that 
changes in lung sounds correspond well with the 20% fall in 
FEV, after a bronchial challenge test (5). Our method is 
simple and requires little equipment. Changes in lung 
sounds detected by tracheal auscultation can be used for the 
assessment of bronchial responsiveness in asthmatic chil- 
dren and would probably offer an attractive method for 
children who are not able to perform spirometry reliably. 
However, the application of the method to younger 
children needs to be further elucidated. 
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